-
Why Immunotherapy Isn’t Perfect & How Scientists Are Working to Fix It
Read time: 3 minutes. The human immune system is an intricate web of checks and balances that usually excels at detecting and destroying foreign invaders, such as bacteria and -
New Horizons in Immunotherapy: Lung Cancer Highlights from the 2025 SITC Meeting
Read time: 2 minutes. The Society for Immunotherapy of Cancer (SITC) celebrated their 40 th anniversary at their annual meeting in National Harbor, Maryland from November 5-9, 2025 -
The Future of Lung Cancer Starts Here
Read time: 1 minute. For more than two decades, LUNGevity Foundation has been a leader in advancing lung cancer research. Since 2002, we have invested $55+ million in more than 200 -
Biggest News from Berlin: Research Highlights from ESMO
Read time: 5 minutes. Lung cancer research was in the spotlight at the European Society for Medical Oncology (ESMO) meeting held October 17-21, 2025, in Berlin, Germany. With -
LUNGevity Foundation Invests $1.2 Million to Fuel Next Generation of Lung Cancer Research
Read time: 6 minutes. LUNGevity Foundation announced $1.2 million in research awards that are designed to strengthen the lung cancer workforce and accelerate progress across the -
Reaping the Rewards of Radiation to Make Immunotherapy More Effective
Read time: 3 minutes. Immune checkpoint inhibitors (ICIs) have revolutionized the way we approach lung cancer treatment over the past decade. These lifesaving drugs block the PD-L1